Literature DB >> 16054388

Steroid signalling in the ovarian surface epithelium.

Michael T Rae1, Stephen G Hillier.   

Abstract

Human ovarian surface epithelium (HOSE) undergoes serial injury-repair with each ovulation, which is probably why most ovarian epithelial cancers arise there. Considering the proposed inflammatory aetiology of ovarian cancer, anti-inflammatory steroid signalling might be vital for HOSE regulation. HOSE cells express hydroxysteroid dehydrogenase (HSD) enzymes that undertake prereceptor metabolism of bioinert steroidogenic precursors formed elsewhere in the body. Ovulation-associated cytokines activate anti-inflammatory cortisol from precursor cortisone in HOSE cells owing to up-regulation of the gene encoding 11betaHSD type 1 (HSD11B1) in vitro. Cortisol further enhances its own formation and action through augmentation of cytokine-induced HSD11B1 and glucocorticoid receptor gene expression. Understanding this feed-forward signalling process has implications for the improved diagnosis and treatment of inflammation-associated reproductive disease states such as ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054388     DOI: 10.1016/j.tem.2005.07.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  8 in total

1.  Dynamics of the primate ovarian surface epithelium during the ovulatory menstrual cycle.

Authors:  Jay W Wright; Leigh Jurevic; Richard L Stouffer
Journal:  Hum Reprod       Date:  2011-03-18       Impact factor: 6.918

2.  Dynamics of the transcriptome in the primate ovulatory follicle.

Authors:  Fuhua Xu; Richard L Stouffer; Jörg Müller; Jon D Hennebold; Jay W Wright; Alistair Bahar; Gabriele Leder; Michaele Peters; Melissa Thorne; Micaela Sims; Tim Wintermantel; Bernhard Lindenthal
Journal:  Mol Hum Reprod       Date:  2010-10-29       Impact factor: 4.025

3.  Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.

Authors:  Jekaterina Patrova; Magnus Kjellman; Hans Wahrenberg; Henrik Falhammar
Journal:  Endocrine       Date:  2017-09-08       Impact factor: 3.633

4.  Adrenocorticotropic hormone suppresses gonadotropin-stimulated estradiol release from zebrafish ovarian follicles.

Authors:  Derek Alsop; Jennifer S Ings; Mathilakath M Vijayan
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

Review 5.  Menstrual physiology: implications for endometrial pathology and beyond.

Authors:  Jacqueline A Maybin; Hilary O D Critchley
Journal:  Hum Reprod Update       Date:  2015-08-07       Impact factor: 15.610

6.  Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.

Authors:  Nina Ditsch; Sabine Heublein; Udo Jeschke; Cornelia Sattler; Christina Kuhn; Anna Hester; Bastian Czogalla; Fabian Trillsch; Sven Mahner; Jutta Engel; Doris Mayr; Elisa Schmoeckel
Journal:  J Cancer Res Clin Oncol       Date:  2020-06-12       Impact factor: 4.553

Review 7.  The Chemoprevention of Ovarian Cancer: the Need and the Options.

Authors:  Rishil J Kathawala; Andrzej Kudelka; Basil Rigas
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

8.  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.

Authors:  Andrew Schrepf; Lauren Clevenger; Desire Christensen; Koen DeGeest; David Bender; Amina Ahmed; Michael J Goodheart; Laila Dahmoush; Frank Penedo; Joseph A Lucci; Parvin Ganjei-Azar; Luis Mendez; Kristian Markon; David M Lubaroff; Premal H Thaker; George M Slavich; Anil K Sood; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2012-08-05       Impact factor: 7.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.